RSS

Janssen Pharmaceuticals

As pharma encounters massive shifts in public perception, which is seemingly negative in the current climate, Nick Johns from ConsumerSafety.org, looks at the focus of pharma in the US and how shifting this could benefit public perception more

Opinion

New data, presented at the 2018 American Academy of Dermatology (AAD) Annual Meeting, has demonstrated that Tremfya (guselkumab) provides long-term skin clearance in patients with moderate to severe plaque psoriasis. more

News

Real world evidence from a study involving almost 30,000 people, supporting the benefits of long-acting antipsychotics (LATs) in reducing the risk of mortality among schizophrenic patients, has been announced by Janssen Pharmaceutical more

News

Written evidence has been published by the Business, Energy and Industrial Strategy Committee, suggesting the impact Brexit may have on the pharmaceutical industry. more

News

Analyst company GBI Research has concluded that due to an increasing demand for type 2 diabetes mellitus (T2DM) therapeutics, there is a large and competitive market landscape. more

News

Due to a price drop, the National Institute for Health and Care Excellence (NICE) has agreed that Janssen’s prostate cancer drug, abiraterone is now affordable, going back on its previous decision more

News

Cypralis, a life sciences company focussed on the discovery of therapeutics for the modulation of peptidyl-prolyl isomerases (PPIases), has entered into a collaboration with Janssen Pharmaceuticals more

News